Keywords: Diagnosis/Prediction, Machine Learning/Artificial Intelligence, lung cancer patients with brain metastasis
Motivation: To determine an effective individualized treatment decision for lung cancer patients with brain metastasis (BrM) to receive targeted therapy.
Goal(s): we developed an MRI-based nomogram that can predict the response of lung cancer BrM to targeted therapy using multi-center data.
Approach: Clinical predictors, radiomics and deep learning features extracted from BrM baseline MR images were incorporated to establish the nomogram using the LASSO logistics coefficients.
Results: The nomogram can accurately predict the 6-month and 12-month responses of BrM to targeted therapy across the training cohort, internal validation cohort, and external test set, outperforming all other models.
Impact: The MRI-based nomogram can be used as a pretreatment and personalized tool to predict response to targeted therapy in lung cancer patients with BrMs and thus assist in optimizing treatment for lung cancer patients who suffer from BrMs.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords